| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/11/2010 | WO2010129954A1 Treatment of ischemia-reperfusion injury |
| 11/11/2010 | WO2010129947A2 Alpha thymosin peptides as vaccine enhancers |
| 11/11/2010 | WO2010129895A2 Cd133 epitopes |
| 11/11/2010 | WO2010129890A2 Compounds and methods for inhibiting platelet aggregation |
| 11/11/2010 | WO2010129789A2 Modified tumor necrosis factor-beta |
| 11/11/2010 | WO2010129707A1 Etanercept in combination with glucocorticoids for use in treating psoriasis |
| 11/11/2010 | WO2010129674A2 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 11/11/2010 | WO2010129655A2 Natriuretic polypeptides having mutations within their disulfide rings |
| 11/11/2010 | WO2010129609A2 Antibodies and methods of use thereof |
| 11/11/2010 | WO2010129600A2 Fgf21 mutants and uses thereof |
| 11/11/2010 | WO2010129547A1 Collagen-binding synthetic peptidoglycans for wound healing |
| 11/11/2010 | WO2010129503A1 Fgf21 mutants and uses thereof |
| 11/11/2010 | WO2010129457A2 Vaccines against tularemia |
| 11/11/2010 | WO2010129406A2 Methods of promoting muscle growth |
| 11/11/2010 | WO2010129347A2 Compositions and methods for the treatment of disorders involving epithelial cell apoptosis |
| 11/11/2010 | WO2010129276A2 PYRO-GLUTAMATE Aβ TARGETING AGENTS |
| 11/11/2010 | WO2010129267A2 Anti-trypanosomal peptides and uses thereof |
| 11/11/2010 | WO2010129248A1 Melanocortin receptor binding conjugates |
| 11/11/2010 | WO2010129233A2 Methods of treating bacterial infections using oritavancin |
| 11/11/2010 | WO2010128672A1 Neovascularization inducer comprising genetically recombined gelatin |
| 11/11/2010 | WO2010128407A2 Anti-il-17f antibodies and methods of use thereof |
| 11/11/2010 | WO2010128159A1 Novel heamoglobin and uses thereof |
| 11/11/2010 | WO2010128141A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker |
| 11/11/2010 | WO2010128098A1 Peptide ligands of somatostatin receptors |
| 11/11/2010 | WO2010128016A2 Par2 agonists for use in the treatment or prevention of influenza virus type a infections |
| 11/11/2010 | WO2010127877A1 Novel compositions for treating pseudomonas infection |
| 11/11/2010 | WO2010127712A1 Influenza a and b virus replication-inhibiting peptides |
| 11/11/2010 | WO2010127704A1 Beta-hairpin peptidomimetics having cxcr4 antagonizing activity |
| 11/11/2010 | WO2010127640A1 High penetration prodrug compositions of peptides and peptide-related compounds |
| 11/11/2010 | WO2010127400A1 Modulation of inducible nitric oxide (inos) binding to spry domain-containing socs-box peptides (ssb) |
| 11/11/2010 | WO2010127381A1 Diagnosis, monitoring, prognosis, prevention and treatment of aneurysms |
| 11/11/2010 | WO2010107486A3 Use of somatostatin or an analogue thereof in combination with external radiation therapy |
| 11/11/2010 | WO2010106542A3 USE OF NKp46 FOR PREVENTING DIABETES |
| 11/11/2010 | WO2010105636A8 Topical compositions comprising interleukin-1 alpha and peptides and cosmetic methods thereof |
| 11/11/2010 | WO2010103515A3 Compositions and methods for prevention and treatment of neurodegenerative diseases |
| 11/11/2010 | WO2010101353A3 Composition containing human serum albumin-timp-2 fusion protein and anti-cancer drug for preventing or treating cancer |
| 11/11/2010 | WO2010099556A8 Method for preventing and treating hyperpermeability |
| 11/11/2010 | WO2010099436A9 Peptidomimetic cyclic compounds for treating retinitis pigmentosa |
| 11/11/2010 | WO2010092577A3 COMPLEMENT C3a DERIVED DIMERIC PEPTIDES AND USES THEREOF |
| 11/11/2010 | WO2010091651A3 Novel antimicrobial peptides |
| 11/11/2010 | WO2010081492A8 Melanocortin analogs with antimicrobial activity |
| 11/11/2010 | WO2010078469A3 Sand fly salivary proteins as novel factor xa inhibitors and methods of use |
| 11/11/2010 | WO2010064258A3 Pharmaceutical formulations of pegylated interferon |
| 11/11/2010 | WO2010004299A3 Pharmaceutical compositions of somatotrophic hormones |
| 11/11/2010 | WO2009142773A9 Multivalent fibronectin based scaffold domain proteins |
| 11/11/2010 | WO2004062646A9 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 11/11/2010 | US20100287637 Methods of blocking tissue destruction by autoreactive t cells |
| 11/11/2010 | US20100287636 Compositions and methods for inhibiting inducible t cell kinase (itk) and treating asthma and bronchial inflammations |
| 11/11/2010 | US20100287625 Vegf variants |
| 11/11/2010 | US20100286793 Device for minimally invasive plastic surgery lift procedure |
| 11/11/2010 | US20100286774 Artificial eardrum using silk protein and method of fabricating the same |
| 11/11/2010 | US20100286762 Compositions and Methods for Ameliorating Clinical Electrical Disturbances |
| 11/11/2010 | US20100286384 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 11/11/2010 | US20100286375 Carrier molecules |
| 11/11/2010 | US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 11/11/2010 | US20100286253 Method for treating ocular neovascularization |
| 11/11/2010 | US20100286246 Identification of novel genes coding for small temporal rnas |
| 11/11/2010 | US20100286245 Identification of novel genes coding for small temporal rnas |
| 11/11/2010 | US20100286239 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation |
| 11/11/2010 | US20100286235 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals |
| 11/11/2010 | US20100286141 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways |
| 11/11/2010 | US20100286072 Retro-inverso peptides derived from interleukin-6 |
| 11/11/2010 | US20100286071 Finger-1 Peptide Analogs of the TGF-Beta Superfamily |
| 11/11/2010 | US20100286070 Affinity tag |
| 11/11/2010 | US20100286069 Cationic peptide for delivering an agent into a cell |
| 11/11/2010 | US20100286068 Molecular markers of plant embryogenesis |
| 11/11/2010 | US20100286067 Glycoconjugation of polypeptides using oligosaccharyltransferases |
| 11/11/2010 | US20100286066 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 11/11/2010 | US20100286065 Topical methods and compositions for the treatment of eye diseases and conditions |
| 11/11/2010 | US20100286064 Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof |
| 11/11/2010 | US20100286063 GNRH agonist combination drugs |
| 11/11/2010 | US20100286062 Pharmaceutical compound |
| 11/11/2010 | US20100286061 Plasmin-inhibitory therapies |
| 11/11/2010 | US20100286060 Specific binding agents of human angiopoeitin-2 |
| 11/11/2010 | US20100286059 Use of opioid antagonists |
| 11/11/2010 | US20100286058 Assessing Chemotherapy Resistance of Colorectal Tumors by Determining Sparc Hypermethylation |
| 11/11/2010 | US20100286057 Methods and compositions for modulating bcl-2 family polypeptides |
| 11/11/2010 | US20100286056 Compositions for reducing oxidative stress and uses thereof |
| 11/11/2010 | US20100286055 Use of wnt3a for acceleration of wound healing |
| 11/11/2010 | US20100286054 Composition |
| 11/11/2010 | US20100286053 Plasminogen activator inhibitor amelioration of newborn hypoxic ischemic brain injury |
| 11/11/2010 | US20100286052 Novel use of antisecretory factor |
| 11/11/2010 | US20100286051 MEMORY AND LEARNING IMPAIRMENTS ASSOCIATED WITH DISRUPTION OF EPHRIN RECEPTOR A6 (EphA6) GENE |
| 11/11/2010 | US20100286050 Method of preventing progression of hypertension-induced heart failure with pkc peptides |
| 11/11/2010 | US20100286049 Polycystic kidney disease-related gene and use thereof |
| 11/11/2010 | US20100286048 Albumin Fusion Proteins |
| 11/11/2010 | US20100286047 Use of vwf stabilized fviii preparations and of vwf preparations without fviii for extravascular administration in the therapy and prophylactic treatment of bleeding disorders |
| 11/11/2010 | US20100286046 Modified h2 relaxin for tumor suppression |
| 11/11/2010 | US20100286045 Methods comprising desmopressin |
| 11/11/2010 | US20100286044 Detection of tissue origin of cancer |
| 11/11/2010 | US20100286043 Use of neuregulin-1 in reducing brain damage |
| 11/11/2010 | US20100286042 Medicinal Composition Containing Highly Functionalized Chimeric Protein |
| 11/11/2010 | US20100286041 (5z)-5-(6-quinoxalinylmethylidene)-2-[(2,6-dichlorophenyl)amino]-1,3-thiazol-4(5h)-one |
| 11/11/2010 | US20100286040 Pro-angiogenic peptides and uses thereof |
| 11/11/2010 | US20100286039 Use of SCF and G-CSF in the Treatment of Cerebral Ischemia and Neurological Disorders |
| 11/11/2010 | US20100286038 Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same |
| 11/11/2010 | US20100286037 Pharmaceutical and/or cosmetic composition containing active-principle activators of aconitase |
| 11/11/2010 | US20100286036 Novel peptides that enhance tight junction permeability |
| 11/11/2010 | US20100286035 Neuromedin u derivative |
| 11/11/2010 | US20100286034 Uses for aqueous streams containing proteins |